# Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening: Advanced Brain Tumor TheRApy Clinical Trial In Patients Scheduled for shOrt Course radiatioN

> **NCT07627334** · NA · RECRUITING · sponsor: **Medical University of Vienna** · enrollment: 30 (estimated)

## Conditions studied

- Glioblastoma (GBM)

## Interventions

- **DIAGNOSTIC_TEST:** CBmed drug screening platform

## Key facts

- **NCT ID:** NCT07627334
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07627334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07627334, "Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening: Advanced Brain Tumor TheRApy Clinical Trial In Patients Scheduled for shOrt Course radiatioN". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07627334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*